I am amazed after fighting cancer for over 15 years how resilient the human spirit is. Throughout my experience, I have ...

This study reveals that the Mediterranean diet may protect against periodontitis, highlighting its benefits for oral health ...

Imagine waking up exhausted despite a full night rsquo;s sleep or noticing bruises that appear without reason, could these be ...

K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies ...

According to Precedence Research, the global cord blood banking services market size will grow from USD 3.27 billion in 2025 to nearly USD 5.81 billion by 2034, with a CAGR of 6.61%. Driven by the ...

The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...

About NEXICART-2 NEXICART-2 (NCT06097832) is an ongoing multi-site U.S. Phase 1/2 clinical trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory AL Amyloidosis, with a registrational ...